Ciba Health Care Sales Rise 8%

Swiss biological and chemical group Ciba says 1995 turnover reached 20.70 billion Swiss francs ($17.42 billion), which represents a 6% rise on 1994 in local currencies. However, due to the continuing strength of the Swiss currency, the rise is just 3% in franc terms.

Sales of health care products, which in 1995 accounted for over 38% of group turnover, advanced 2% in francs and 8% in local currencies, to reach 7.99 billion ($6.73 billion). Within this, pharmaceutical sales were 5.83 billion francs (down 5% in francs but up 5% in local currencies); self-medication saw a massive 23% rise in local currencies (12% up in francs) to 1.05 billion francs, and Ciba Vision sales were 1.12 billion francs, up 8% in local currency and down 2% in francs.